Mariotti A, Mawhinney M
J Urol. 1983 Jan;129(1):180-5. doi: 10.1016/s0022-5347(17)51978-3.
Our previous research has shown that 4 weeks of daily estrogen treatment, started on the day of castration, resulted in significant growth of the guinea pig seminal vesicle smooth muscle, yet little or no estrogenic effect on muscle tissue weight or DNA content was observed when the treatment was initiated after a 1-month period of castration induced regression. With the hypothesis that castration induced reductions in estrogenic sensitivity were due to alterations in the intracellular fate of estradiol in the muscle, we determined, following the intravenous injection of 3H-estradiol to normal, 24-hour castrates and 1-month castrates, the whole muscle tissue accumulation and subcellular distribution of 3H-estradiol. In the same 3 experimental groups, we also determined, using in vitro exchange assays with 3H-estradiol, the number of estrogen binding sites in both the cytosol and salt (1.2 M KCl) soluble fraction of the crude nuclear-myofibrillar pellet. It was found that the loss of estrogenic sensitivity in the 1-month castrate was not due to a reduction in either whole tissue accumulation, subcellular distribution, cytosol binding or salt-soluble nuclear binding of 3H-estradiol. Restoration of estrogenic responses in muscle DNA content and wet weight was achieved by priming 1-month castrates with 5 daily injections of dihydrotestosterone immediately prior to the onset of estrogen treatment. Shorter periods of androgen priming (e.g., 1, 2 or 3 days) slightly enhanced, but did not completely restore, estrogenic responses in muscle wet weight and DNA content. For estrogen sensitive parameters of muscle growth, such as collagen and RNA content, which were not altered in their response to the estrogen treatment by a 1-month period of castration-induced regression, androgen priming prior to estrogen treatment had no effect. Therefore, testicular androgens regulate selected facets of estrogenic sensitivity in guinea pig seminal vesicle smooth muscle; changes in the muscle cytosol or salt-soluble nuclear myofibrillar estrophiles do not appear to be responsible for the changes in estrogenic sensitivity.
我们之前的研究表明,在去势当天开始进行为期4周的每日雌激素治疗,会使豚鼠精囊平滑肌显著生长,然而,当在去势诱导退化1个月后开始治疗时,对肌肉组织重量或DNA含量几乎没有或没有观察到雌激素效应。基于去势诱导的雌激素敏感性降低是由于肌肉中雌二醇细胞内命运改变的假设,我们在向正常豚鼠、去势24小时的豚鼠和去势1个月的豚鼠静脉注射3H-雌二醇后,测定了全肌肉组织中3H-雌二醇的积累和亚细胞分布。在相同的3个实验组中,我们还使用3H-雌二醇的体外交换试验,测定了粗核-肌原纤维沉淀的细胞质和盐(1.2M KCl)可溶性部分中的雌激素结合位点数量。结果发现,去势1个月的豚鼠雌激素敏感性的丧失并非由于3H-雌二醇的全组织积累、亚细胞分布、细胞质结合或盐溶性核结合减少所致。在雌激素治疗开始前,通过对去势1个月的豚鼠连续5天注射二氢睾酮进行预处理,可恢复肌肉DNA含量和湿重的雌激素反应。较短时间的雄激素预处理(如1、2或3天)略有增强,但未完全恢复肌肉湿重和DNA含量的雌激素反应。对于肌肉生长的雌激素敏感参数,如胶原蛋白和RNA含量(在去势诱导退化1个月期间,它们对雌激素治疗的反应未发生改变),雌激素治疗前的雄激素预处理没有影响。因此,睾丸雄激素调节豚鼠精囊平滑肌中雌激素敏感性的特定方面;肌肉细胞质或盐溶性核肌原纤维雌激素受体的变化似乎不是雌激素敏感性变化的原因。